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Abstract
Peripheral chemoreflex activation with potassium cyanide (KCN) in awake 
rats, or in the working heart brainstem preparation (WHBP) produces: (a) 
a pressor response and sympathoexcitation; (b) bradycardia; and (c) tachy-
pnea and an increase in the frequency of phrenic nerve activity (PNA). During 
the last few years in our laboratory, we have studied the neurotransmis-
sion of the sympathoexcitatory components of the chemoreflex within the 
nucleus tractus solitary (NTS) in unanesthetized experimental models. 
Re cently, we verified that simultaneous antagonism of ionotropic gluta-
mate receptors and purinergic P2 receptors by sequential microinjections 
of kynurenic acid (a non selective antagonist of ionotropic glutamate re-
ceptors) and PPADS (a non-selective antagonist of P2 receptors) into the 
NTS elicited a significant reduction in the pressor and bradycardic re-
sponses but no changes in the tachypneic response to chemoreflex acti-
vation in awake rats. Microinjection of kynurenic acid and PPADS into the 
caudal commissural NTS of the WHBP almost abolished the increase in 
thoracic sympathetic activity and the bradycardic response but produced 
no change in the increase of the frequency of PNA. The data indicate that 
combined microinjections of PPADS and kynurenic acid into the NTS are 
required to block the sympathoexcitatory response to peripheral chem-
oreflex activation, suggesting an interaction of L-glutamate and ATP in this 
neurotransmission. In this review, I explain why we are using unanesthe-
tized models in our experiments and also present the perspectives for 
a better understanding of the complex interaction of glutamatergic and 
purinergic mechanisms involved in the processing of the sympathoexcita-
tory component of the chemoreflex at the NTS level. [Tzu Chi Med J 2009;
21(1):6–11]
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1. Introduction
The question as to why we need to study the neurotrans-
mission of the peripheral chemoreflex in the nucleus 
tractus solitary (NTS) of unanesthetized experimental 
models is an interesting one. I have been asking my-
self this for the last 15 years and each time I receive 
criticisms from reviewers about manuscripts submit-
ted from our laboratory, I try to convince myself that 
I am heading in the right direction. In this mini-review, 
I summarize the reasons and the main findings from 
our laboratory [1] and also include some perspectives 
for the experiments using animal models without 
anesthetic effects.
2. Awake rats
Considering that most of my scientific training has 
been in integrative physiology, I have a natural ten-
den cy to become involved in experiments using unan-
esthetized models. When my colleagues and I started 
our studies on the neurotransmission in the NTS, the 
initial idea was to explore the nucleus for possible 
changes in the pharmacological profile of L-glutamate 
ionotropic receptors after sinoaortic deafferentation 
in rats. For this purpose, we used a method described 
by Michelini and Bonagamba [2], which allowed mi-
croinjections to be performed in the NTS of awake 
rats. However, we verified that microinjections of L-
glutamate into the NTS of unanesthetized rats pro-
duced pressor responses, while microinjections of the 
same dose of L-glutamate in the same animals under 
urethane or chloralose anesthesia produced depres-
sor responses [3]. These findings were important for 
several reasons: (a) L-glutamate elicited a pattern of 
cardiovascular responses different from those expected 
for the putative neurotransmitter of the baroreflex, i.e. 
hypotension; and (b) the pressor responses observed 
in the unanesthetized group but not in the anesthe-
tized group suggested a possible predominance of the 
activation of the chemoreflex pathways by L-glutamate. 
Therefore, the initial finding that L-glutamate might 
activate the chemoreflex pathways in unanesthetized 
rats but not in the anesthetized rats opened an inter-
esting opportunity for us to explore the possible role 
of L-glutamate in the neurotransmission of the pres-
sor (sympathoexcitatory) component of the chemo-
reflex in the NTS of awake rats, because the pressor 
responses to chemoreflex activation were abolished 
in anesthetized rats [4,5].
During a series of subsequent studies, we tested 
the hypothesis that L-glutamate acting on ionotropic 
receptors might be the neurotransmitter of the sym-
pa thoexcitatory component of the chemoreflex in the 
NTS of awake rats. These experiments were performed 
even though very important studies in rats under 
anesthesia were published at that time, which docu-
mented that the pressor responses to chemoreflex 
activation were almost abolished by antagonism of 
the ionotropic receptors of L-glutamate [6,7]. Initially, 
we used AP-5, an antagonist of NMDA receptors, and 
we verified that the bradycardic, but not the pressor 
response, was reduced in a dose-dependent manner, 
indicating that the pressor/sympathoexcitatory com-
ponent of the chemoreflex was not mediated by the 
NMDA receptors [8]. Although we did not record the 
sympathetic nerve activity in awake rats, we were con-
vinced that the pressor responses to chemoreflex ac-
tivation were mediated by the sympathetic activity 
because the increase in pressure was blocked by pra-
zosin (iv), an α1 adrenoceptor antagonist [8]. A sub-
se quent experiment with antagonism of non-NMDA 
receptors was mandatory and, for this purpose, we 
used DNQX, a selective non-NMDA receptor antago-
nist. The data showed that the pressor responses 
after DNQX administration into the NTS were reduced 
but we also observed a significant increase in the base-
line MAP, which could affect and reduce the magnitude 
of the pressor responses to chemoreflex activation. 
Despite the increase in baseline MAP, we verified that 
the pressor responses to chemoreflex activation were 
not blocked by DNQX, even at a range of doses that 
were not selective to non-NMDA receptor subtypes. 
Con sidering that the pressor responses were not 
blocked by selective antagonism of non-NMDA recep-
tors, we used kynurenic acid, a non-selective antagonist 
of ionotropic receptor of L-glutamate and, surprisingly, 
we were unable to block the pressor responses of 
the chemoreflex [9]. The manipulation of the NTS with 
kynurenic acid or DNQX produced large increases in 
the baseline MAP in intact animal models due to the 
possible blockade of the sympathoinhibitory compo-
nent of the baroreflex, which may mask the net effect 
of these antagonists on the pressor responses to che-
moreflex activation. Therefore, the next step was to 
normalize the large increases in the baseline MAP 
observed after microinjections of kynurenic acid into 
the NTS and, for this reason, we used intravenous in-
fusion of sodium nitroprusside. Under this experimen-
tal condition, the chemoreflex was activated again 
and we observed that the magnitude of the pressor 
responses, when the baseline MAP had reverted to 
normal levels, was similar to the control responses. 
This indicated that in whole animal models the an-
tagonism of L-glutamate ionotropic receptors in the 
NTS produced no effects on the pressor responses 
to chemoreflex activation [10]. Despite these findings, 
the data were not sufficient to exclude the involve-
ment of L-glutamate in the neurotransmission of the 
sympathoexcitatory component of the chemoreflex in 
the NTS. However, at the same time, we started to con-
sider other potential neurotransmitters, focusing on 
ATP because of important evidence about the role of 
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this purine on chemosensory transduction in the cen-
tral nervous system [11,12] and in the NTS [13,14].
Microinjections of ATP into the caudal aspect of the 
commissural NTS of unanesthetized rats produced 
increases in MAP similar to the pressor responses to 
chemoreflex activation [15,16], suggesting the involve-
ment of ATP in the processing of the sympathoex-
citatory component of the chemoreflex in the NTS. 
A possible interaction between ATP and L-glutamate 
in the neurotransmission of the sympa thoexcitatory 
component of the chemoreflex at the NTS level was 
also considered. However, in an experimental proto-
col involving microinjection of ATP into the NTS before 
and after local microinjection of kynurenic, the pres-
sor responses to ATP were not affected by the antago-
nism of L-glutamate ionotropic receptors [17]. To test 
the direct involvement of purinergic receptors in the 
processing of the chemoreflex in the NTS, we acti-
vated this reflex before and after bilateral microinjec-
tion of PPADS into the caudal commissural NTS, but 
no changes in the magnitude of the pressor responses 
were observed [1]. Based on the experimental evi-
dence that microinjections of L-glutamate or ATP mi-
croinjected into the NTS produced pressor responses 
similar to those produced by chemoreflex activation, 
but that the selective antagonism of the ionotropic/
metabotropic receptors of L-glutamate or the antag-
onism of P2X receptors of ATP produced no changes 
in the magnitude of the pressor responses to chemo-
reflex activation, we considered the possibility that 
both neurotransmitters might be interacting in the 
processing of the sympathoexcitatory component 
at the NTS. Accordingly, we performed simultaneous 
block ade of both groups of receptors [1].
3. Antagonism of L-glutamate and ATP 
receptors
Double antagonism of L-glutamate and ATP receptors 
in the NTS of awake rats produced large increases 
in the baseline MAP and, for the reasons mentioned 
above, we used sodium nitroprusside infusion to 
normalize MAP. Under this experimental condition, 
the chemoreflex was activated and we verified that 
the double antagonism largely abolished the pressor 
responses to chemoreflex activation, an antagonism 
which was reversible, considering that, 30 minutes 
after the microinjection, the patterns of the pressor 
responses were back to the control level [1]. Although 
the pressor responses to chemoreflex activation were 
almost abolished by double antagonism in the NTS of 
awake rats, the data were not enough to prove that 
the sympathetic activity was really affected because, 
as part of several regulatory mechanisms in whole 
animal models, the arterial blood pressure parame-
ter may be affected by different neural and hormonal 
components, which explains the large increases in the 
baseline MAP. The undesirable effects may counter-
balance the changes elicited by manipulations in the 
NTS, masking a clear evaluation of the neurotrans-
mission of a specific reflex such as the sympathoex-
citatory component of the chemoreflex. Given that 
recording the sympathetic nerve activity in awake rats 
while placing microinjections into the correct spots in 
the NTS is not a simple task, we decided to use work-
ing heart-brainstem preparations (WHBP) developed 
by Paton [18] to confirm these findings.
4. Working-heart brainstem
preparation
To help us to evaluate the roles of L-glutamate and 
ATP receptors in the neurotransmission of the sym-
pathoexcitatory component of the chemoreflex, we 
used the WHBP. This was done for several important 
experimental reasons: (a) similar to awake rats, it is 
free of anesthetic despite losing forebrain structures; 
(b) accessing and recording the thoracic sympathetic 
chain and the phrenic nerve are relatively easy com-
pared with the same approach in awake rats; (c) the 
success of correctly targeting the commissural NTS 
with microinjections is greatly improved; (d) the per-
fusion pressure is not affected by NTS microinjec-
tions of antagonists, thereby avoiding activation of the 
arterial baroreceptors; and (e) activation of the chemo-
reflex in the WHBP with KCN presents large increases 
in the sympathetic and phrenic nerve activities, in addi-
tion to bradycardic responses similar to the pattern of 
responses observed in awake rats [16,19].
The first approach in the WHBP was to verify the 
effects of bilateral microinjections of PPADS into the 
commissural NTS on the autonomic and respiratory 
responses to chemoreflex activation. The data showed 
that the chemoreflex responses were not affected by 
bilateral microinjection of PPADS, an antagonist of P2X 
receptors. For the next experimental protocols in the 
WHBP, we used double antagonism with kynurenic acid 
and PPADS. This combination, similar to the findings 
in awake rats, was effective in blocking the sympa-
thoexcitatory response to chemoreflex activation [1]. 
Therefore, the data obtained in the WHBP not only 
confirmed the previous observations in awake rats 
but extended it to the concept that the effective an-
tagonism of the sympathoexcitatory component of the 
chemoreflex was possible only when we combined 
the antagonism of L-glutamate and ATP receptors in 
the caudal commissural NTS.
The findings obtained in awake rats and in the 
WHBP showing that only the combined antagonism 
of L-glutamate and ATP receptors were effective in the 
blockade of the sympathoexcitatory response of the 
chemoreflex are really important; this is especially 
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true when one considers that our previous NTS mi-
croinjections studies in awake rats and in the WHBP 
all failed to block the pressor/sympathoexcitatory re-
sponses to chemoreflex activation. In these previous 
studies we used microinjections of L-glutamate iono-
tropic and metabotropic receptor antagonists [8–10,20], 
GABA agonists [21,22], glycine [23], adenosine recep-
tor antagonists [15] and a substance P receptor an-
tagonist [24]. Based on these negative findings, we 
pro posed that an additional neurotransmitter in the 
NTS may take part in mediating the sympathoexcita-
tory component of the chemoreflex. Therefore, our re-
cent studies were based on the notion that P2X and 
ionotropic L-glutamate receptors in the NTS partici-
pate in the expression of the sympathoexcitatory com-
ponent of the chemoreflex. Moreover, our findings that 
the pressor/sympathoexcitatory response to chemo-
reflex activation was almost abolished by this com-
bined antagonism in the commissural NTS in awake 
rats and in the WHBP strongly support the concept 
that these two neurotransmitters play a pivotal role in 
processing the sympathoexcitatory component of this 
reflex.
5. Explanation of why only double 
antagonism was effective in blocking 
pressor/sympathoexcitatory 
responses to chemoreflex activation
While there is evidence that ATP acting on P2X recep-
tors may induce glutamate release [25], the specific 
involvement in the neurotransmission of the auto-
nomic components of the chemoreflex in the NTS is 
not yet known. Studies performed on unidentified NTS 
neurons by Kato and Shigetomi [26] showed that ATP 
increased the spontaneous postsynaptic currents, 
which were blocked by PPADS, indicating that this 
excitatory effect was mediated by P2X receptors. 
Studies by Jin et al [27] showed that activating P2 
receptors with ATP or α,β-methylene ATP, a stable 
ATP analog, in the NTS facilitated presynaptic gluta-
mate release. Shigetomi and Kato [28] also showed 
that activation of presynaptic P2X receptors with α,β-
methylene ATP triggered Ca2+-dependent glutamate 
release in the NTS. Therefore, it is conceivable that 
ATP, acting presynaptically, may induce glutamate re-
lease in the NTS to mediate the chemoreflex sym-
pathoexcitatory/pressor response. Because ATP can 
be co-released with other neurotransmitters [29], it is 
possible that ATP and L-glutamate are both involved 
in processing the sympathoexcitatory component of 
the chemoreflex. However, the previous findings about 
the interaction between ATP and L-glutamate at the 
same neurons at the presynaptic levels are not consis-
tent with our findings because, in accordance with this 
interaction at the presynaptic level, only the antagonism 
of ATP receptors at the presynaptic level or L-glutamate 
receptors at the post-synaptic level should be enough 
to block the sympathoexcitatory pathways of the che-
moreflex in the NTS. This was, however, not the case 
in awake rats or in the WHBP. Our findings suggest 
that both ionotropic glutamate and P2 receptors in 
the commissural NTS play key roles in the complex 
neurochemical mechanisms expressing the pattern 
of cardiovascular responses to chemoreflex activation. 
Moreover, this suggests redundancy within the NTS be-
cause, based on our findings, if one of these systems 
(glutamatergic or purinergic) fails, the sympathoexci-
tatory component of the chemoreflex remains func-
tional. To explain this possibility we suggest that NTS 
neurons projecting to the RVLM might be mediated 
by L-glutamate, while NTS neurons projecting to the 
paraventricular nucleus of hypothalamus (PVN) and/
or to parabrachial nucleus (PBN), nuclei that are also 
involved in the sympathoexcitatory component of the 
chemoreflex, might be mediated by ATP, or vice versa. 
These possibilities need to be evaluated in further 
electrophysiological studies.
We propose that in unanesthetized preparations 
such as awake rats and WHBP, this dual neurotrans-
mitter system for the sympathoexcitatory component 
of the chemoreflex emphasizes the vital importance 
of this protective reflex and its importance for survival. 
However, dysfunction of these complex neuronal and 
neurochemical systems may affect the modulation of 
the sympathetic outflow and result in increases in arte-
rial pressure. For this reason, we believe that our find-
ings provide new perspectives for pharmacological 
therapy for reducing sympathoexcitation during path-
ophysiological conditions such as neurogenic hyper-
tension, obstructive sleep apnea and heart failure.
6. Perspectives
The findings that only double antagonism of L-glutamate 
ionotropic receptors and ATP P2 receptors were effec-
tive in blocking the sympathoexcitatory component 
of the chemoreflex open several interesting perspec-
tives for studies aimed at a better understanding of 
the central mechanisms involved in the generation 
of sympathetic over-excitation, which may induce hy-
pertension. To verify whether this interaction is re-
stricted to the NTS level, further experiments at the 
RVLM level must be performed to verify whether sim-
ilar interactions of these dual systems occur at sites 
where the sympathetic activity is originally generated. 
Taking into account that the interaction between ATP 
and L-glutamate apparently is not restricted to a simple 
and direct interaction between these two neurotrans-
mitters on their specific receptors, further studies are 
needed to determine whether another neuromodula-
tory mechanism such as nitric oxide and/or GABA, 
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for example, plays a role in this interaction. With 
respect to the electrophysiological approach, it is 
cri tical to determine whether the excitation of NTS 
neurons projecting to the RVLM are mediated equally 
by L-glutamate and ATP or whether there are differ-
ent neurochemical profiles for those neurons of the 
NTS projecting to RVLM that are directly involved with 
the sympathoexcitatory pathways of the chemoreflex. 
Because the modulation of the sympathoexcitatory 
responses to chemoreflex activation is not restricted 
to the NTS-RVLM projections, it is essential to investi-
gate the NTS neurons that send projections to the PVN 
and PBN, which are also integral to the sympathoex-
citatory chemoreflex pathways. It is very important 
to note that, in future cases in which we are able to 
explore most of the sympathoexcitatory pathways of 
the chemoreflex in the NTS, it may not be enough to 
explain this complex interaction of L-glutamate and 
ATP. On this point, it is essential to consider the role 
of the ventilatory components in the chemoreflex on 
this complex interaction system, because the respi-
ratory rhythm is coupled with modulation of the sym-
pathetic activity. Therefore, the integrative systems of 
the cardiovascular and respiratory functions must be 
evaluated using only preparations free of anesthetics. 
This will allow us to better understand this vital, com-
plex and potentially dangerous integrative system, in 
which L-glutamate and ATP are just two of several im-
portant players in the modulation of this sophisticated 
system essential for our life, which does not include 
any anesthetic as a natural player.
Acknowledgments
The studies performed in the author’s laboratory in 
Brazil were supported by the FAPESP (Fundação de 
Amparo à Pesquisa do Estado de São Paulo) and CNPq 
(Conselho Nacional de Desenvolvimento Científico e 
Tecnológico). The author would like to thank his coau-
thors on the publications related to this topic for gener-
ating data and the ideas presented in this mini-review.
References
 1. Braga VA, Soriano RN, Braccialli AL, et al. Involvement of 
L-glutamate and ATP in the neurotransmission of the sympa-
thoexcitatory component of the chemoreflex in the com-
missural nucleus tractus solitarii of awake rats and in the 
working heart-brainstem preparation. J Physiol 2007;581:
1129–45.
 2. Michelini LC, Bonagamba LGH. Baroreceptor reflex modu-
lation by vasopressin microinjected into the nucleus trac-
tus solitarii of conscious rats. Hypertension 1988;11:
75–9.
 3. Machado BH, Bonagamba LGH. Microinjection of L-glutamate 
into the nucleus tractus solitarii increases arterial pressure 
in conscious rats. Brain Res 1992;576:131–8.
 4. Franchini KG, Krieger EM. Cardiovascular responses of 
conscious rats to carotid body chemoreceptor stimulation 
by intravenous KCN. J Auton Nerv Syst 1993;42:63–9.
 5. Machado BH. Chemoreflex and sympathoexcitation. In: Dun 
NJ, Machado BH, Pilowsky PM, eds. Neural Mechanisms of 
Cardiovascular Regulation. Norwell, MA: Kluwer Academic 
Publishers, 2004:31–58.
 6. Vardhan A, Kachroo A, Sapru HN. Excitatory amino acid 
receptors in commissural nucleus of the NTS mediate 
carotid chemoreceptor responses. Am J Physiol 1993;264:
R41–50.
 7. Zhang W, Mifflin SW. Excitatory amino acid receptors with in 
NTS mediate arterial chemoreceptor reflexes in rats. Am 
J Physiol 1993;265:H770–3.
 8. Haibara AS, Colombari E, Chianca DA Jr, Bonagamba LG, 
Machado BH. NMDA receptors in NTS are involved in 
bradycardic but not in pressor response of chemoreflex. 
Am J Physiol Regul Integr Comp Physiol 1995;269:
H1421–7.
 9. Haibara AS, Bonagamba LGH, Machado BH. Neurotrans-
mission of the sympatho-excitatory component of chemo-
reflex in the nucleus tractus solitarii of unanesthetized 
rats. Am J Physiol 1999;276:R69–80.
10. Machado BH, Bonagamba LGH. Antagonism of glutamate 
receptors in the intermediate and caudal commissural 
NTS of awake rats produced no changes in the hyperten-
sive response to chemoreflex activation. Auton Neurosci 
2005;117:25–32.
11. Spyer KM, Dale N, Gourine AV. ATP is a key mediator 
of central and peripheral chemosensory transduction. 
Exp Physiol 2004;89:53–9.
12. Gourine AV, Llaudet E, Dale N, Spyer KM. ATP is a media-
tor of chemosensory transduction in the central nervous 
system. Nature 2005;436:108–11.
13. Phillis JW, Scislo TJ, O’Leary DS. Purines and the nucleus 
tractus solitarius: effects on cardiovascular and respira-
tory function. Clin Exp Pharmacol Physiol 1997;24:
738–42.
14. Paton JFR, de Paula PM, Spyer KM, Machado BH, Boscan P. 
Sensory afferent selective role of P2 receptors in the 
nucleus tractus solitarii for mediating the cardiac compo-
nent of the peripheral chemoreceptor reflex in rats. 
J Physiol 2002;543:995–1005.
15. de Paula PM, Machado BH. Antagonism of adenosine A1 
receptors in the NTS does not affect the chemoreflex in 
awake rats. Am J Physiol Regul Integr Comp Physiol 
2001;281:R2072–8.
16. Antunes VR, Braga VA, Machado BH. Autonomic and respi-
ratory responses to microinjection of ATP into the inter-
mediate or caudal nucleus tractus solitarius in the working 
heart–brainstem preparation of the rat. Clin Exp Pharmacol 
Physiol 2005;32:467–72.
17. de Paula PM, Antunes VR, Bonagamba LG, Machado BH. 
Cardiovascular responses to microinjection of ATP into 
the nucleus tractus solitarii of awake rats. Am J Physiol 
Regul Integr Comp Physiol 2004;287:R1164–71.
18. Paton JFR. A working heart-brainstem preparation of the 
mouse. J Neurosci Methods 1996;65:63–8.
19. Antunes VR, Bonagamba LG, Machado BH. Hemodynamic 
and respiratory responses to microinjection of ATP into 
the intermediate and caudal NTS of awake rats. Brain Res 
2005;1032:85–93.
20. Braga VA, Machado BH. Chemoreflex sympathoexcitation 
was not altered by the antagonism of glutamate receptors 
in the commissural nucleus tractus solitarii in the working 
 TZU CHI MED J  March 2009  Vol 21  No 1 11
  heart-brainstem preparation of rats. Exp Physiol 2006;91:
551–9.
21. Callera JC, Sévoz C, Laguzzi R, Machado BH. Microinjection 
of serotonin3 receptor agonist into the NTS of unanesthe-
tized rats inhibits the bradycardia evoked by activation of 
the baro- and chemoreflex. J Auton Nerv Syst 1997;63:
127–36.
22. Callera JC, Bonagamba LG, Nosjean A, Laguzzi R, Machado 
BH. Activation of GABAA but not GABAB receptors in the 
NTS blocked bradycardia of chemoreflex in awake rats. 
Am J Physiol 1999;276:H1902–10.
23. Pimentel FF, Bonagamba LGH, Machado BH. Pressor res-
ponse to chemoreflex activation before and after microin-
jection of glycine into the NTS of awake rats. Am J Physiol 
2003;284:R1000–9.
24. Zhang CH, Bonagamba LGH, Machado BH. Blockade of 
NK-1 receptors in the lateral commissural nucleus tractus 
solitarii of awake rats had no effect on the cardiovascular 
responses to chemoreflex activation. Braz J Med Biol Res 
2000;33:1379–85.
25. Gu JG, MacDermott AB. Activation of ATP P2X receptors 
elicits glutamate release from sensory neuron synapse. 
Nature 1997;389:749–53.
26. Kato F, Shigetomi E. Distinct modulation of evoked and 
spontaneous EPSCs by purinoceptors in the nucleus trac-
tus solitarii of the rat. J Physiol 2001;530:469–86.
27. Jin YH, Bailey TW, Li BY, Schild JH, Andresen MC. Purinergic 
and vanilloid receptor activation releases glutamate from 
separate cranial afferent terminals in nucleus tractus soli-
tarius. J Neurosc 2004;24:4709–17.
28. Shigetomi E, Kato F. Action potential-independent release 
of glutamate by Ca2+ entry through presynaptic P2X recep-
tors elicits postsynaptic firing in the brainstem autonomic 
network. J Neurosci 2004;24:3125–35.
29. Burnstock G. Purines and cotransmitters in adrenergic and 
cholinergic neurons. Prog Brain Res 1986;68:193–203.
